Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Six Monthly Return

5 Dec 2008 14:28

RNS Number : 6401J
Ark Therapeutics Group PLC
05 December 2008
 



Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme 

3.  Period of return

From 3/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

2,536,252

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

5,000

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

2,531,252

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan 

3.  Period of return

From 3/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

939,433

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

Nil

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

3.  Period of return

From 9/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

Nil

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

1,000,000

6.  Less: Number of securities issued/allotted under the scheme during period

7,750

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

992,250

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Approved Share Option Plan

3.  Period of return

From 9/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

Nil

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

1,000,000

6.  Less: Number of securities issued/allotted under the scheme during period

Nil

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRUVUSRWRRURAA
Date   Source Headline
14th Apr 20102:09 pmRNSRule 8.3- Ark Therapeutics Group PLC
14th Apr 201011:41 amRNSEPT Disclosure-Amendment
13th Apr 201012:08 pmBUSRule 8.3 - Ark Therapeutics Group plc
13th Apr 201011:34 amRNSEPT Disclosure
13th Apr 201011:31 amRNSRule 8.3- ARK THERAPEUTICS
13th Apr 201011:29 amRNSEPT Disclosure
12th Apr 201011:22 amRNSEPT Disclosure
12th Apr 201010:19 amRNSEPT Disclosure
12th Apr 20107:00 amRNSResearch Update
9th Apr 201011:35 amRNSEPT Disclosure
9th Apr 201011:33 amRNSEPT Disclosure- Amendment
9th Apr 20109:28 amRNSEPT Disclosure
8th Apr 20102:43 pmRNSEPT Disclosure-Amendment
8th Apr 201012:27 pmRNSEPT Disclosure
8th Apr 201010:43 amRNSRule 8.3- ARK THERAPEUTICS
8th Apr 20108:33 amRNSEPT Disclosure
7th Apr 20104:08 pmRNSAnnual Information Update
7th Apr 201010:59 amRNSRule 8.3- ARK THERAPEUTICS
1st Apr 201011:03 amRNSArk Therapeutics Group plc
1st Apr 201011:00 amRNSEPT Disclosure
1st Apr 201010:37 amRNSEPT Disclosure
31st Mar 20103:42 pmRNSTotal Voting Rights
31st Mar 20102:00 pmBUSRule 8.3 - ARK THERAPEUTICS GROUP PLC
31st Mar 201010:37 amRNSEPT Disclosure
30th Mar 201012:48 pmRNSEPT Disclosure
30th Mar 201012:42 pmBUSRule 8.3 - Ark Therapeutics Group plc
25th Mar 201012:08 pmBUSRule 8.3 - Ark Therapeutics Group plc
25th Mar 201010:53 amRNSEPT Disclosure
24th Mar 201011:52 amRNSEPT Disclosure
24th Mar 201011:15 amRNSEPT Disclosure
24th Mar 201010:25 amBUSRule 8.3 - Ark Therapeutics Group plc
22nd Mar 20101:48 pmRNSRule 8.3- ARK THERAPEUTICS GROUP PLC
22nd Mar 20101:42 pmRNSRule 8.3- ARK THERAPEUTICS GROUP PLC
22nd Mar 20101:24 pmBUSRule 8.3 - ARK THERAPEUTICS GROUP PLC
22nd Mar 201011:45 amRNSEPT Disclosure
22nd Mar 201010:18 amRNSEPT Disclosure
19th Mar 20104:58 pmRNSRule 8.3- (Ark Therapeutics Group Plc)
19th Mar 20102:56 pmRNSRule 8.3- Ark Therapeutics Group plc
19th Mar 20101:30 pmBUSRule 8.3 - Ark Therapeutics Group plc
19th Mar 201011:45 amRNSEPT Disclosure
19th Mar 201010:30 amRNSEPT Disclosure
18th Mar 201012:14 pmRNSEPT Disclosure
17th Mar 201010:38 amRNSEPT Disclosure
16th Mar 20103:55 pmRNSHolding(s) in Company
16th Mar 201011:12 amRNSEPT Disclosure
15th Mar 201011:30 amRNSEPT Disclosure
15th Mar 201010:34 amRNSEPT Disclosure
11th Mar 201011:49 amRNSEPT Disclosure
10th Mar 20104:40 pmRNSSecond Price Monitoring Extn
10th Mar 20104:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.